The report "Spinal Implants Market by Product (Devices (Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion), Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028", is projected to reach USD 14.3 billion by 2028 from USD 11.2 billion in 2023, growing at a CAGR of 5.0% during the forecast period. The expansion of the spinal implants market is propelled by several synergistic factors, including increasing demand for minimally invasive surgical procedures, escalating spinal disorder prevalence, rising geriatric patient population, growing public-private investments to support for the clinical research and the presence of key market players in developing regions.
Browse 359 market data Tables and 45 Figures spread through 335 Pages and in-depth TOC on "Spinal Implants Market by Product (Devices (Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion), Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/spine-surgery-devices-market-712.html
Non-Fusion Devices segment to register a significant growth rate over the forecast period of 2022-2028.
Based on the product, the spinal implants market is segmented into Thoracic Fusion and lumbar Fusion Devices, Cervical Fusion Devices, Spine Biologics, Spinal Decompression Devices, Non-Fusion Devices, Vertebral Compression Fracture Treatment Devices, and Spine Bone Stimulators. The surge in spinal disorder and non-fusion procedures often involve less disruption to surrounding tissues and may result in shorter recovery times. Furthermore, The adoption of non-fusion devices in spinal implants reflects a shift toward more patient-centered, minimally invasive approaches that aim to address spinal conditions while preserving motion and reducing the potential for complications associated with fusion surgeries are significant contributors to this segment's substantial market share.
Open Surgeries segment accounted for the significant share of the spinal implants market in 2022-2028.
Based on the type of surgery, Open Surgeries is the preferred application for surgeons in spine surgical procedures for complex spinal deformities, such as severe scoliosis or advanced kyphosis. The direct visualization provided by open procedures allows surgeons to address intricate anatomical abnormalities more effectively. Additionally, In trauma cases, open procedures are often used when the surgeon needs quick access to treat fractures, dislocations, and other severe injuries., is anticipated to bolster the segment's growth.
North America to account for a significant market share in the spinal implants market in 2022.
Based on region, The spinal implants market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with North America dominating the market share in 2022. This dominance in North America is propelled by factors such as a growing elderly population, a high incidence of spinal disorder, a rise in demand for minimally invasive surgical procedures, and the presence of well-established players with robust spinal implants portfolios. Furthermore, growing research and funding initiatives from public and private organizations are expected to further boost the spinal implants market in North America.
As of 2022, prominent players in the spinal implants market are Medtronic (Ireland), Depuy Synthes- Johnson & Johnson (US), NuVasive (US), Spineart (Switzerland), RTI Surgical (Germany), Zimmer Biomet Holdings (US), Globus Medical Inc. (US), Abbott Laboratories (US) and Boston Scientific Corporation (US), Stryker Corporation (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]